Inspire Medical Systems (INSP) CEO Timothy P. Herbert Sells 15,000 Shares

Share on StockTwits

Inspire Medical Systems (NASDAQ:INSP) CEO Timothy P. Herbert sold 15,000 shares of the stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $56.47, for a total transaction of $847,050.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of NASDAQ:INSP traded up $0.85 during mid-day trading on Thursday, hitting $56.82. The stock had a trading volume of 404,702 shares, compared to its average volume of 367,729. Inspire Medical Systems has a 12-month low of $22.50 and a 12-month high of $64.34.

Inspire Medical Systems (NASDAQ:INSP) last issued its quarterly earnings results on Tuesday, February 26th. The company reported ($0.22) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.32) by $0.10. The firm had revenue of $16.56 million during the quarter, compared to analysts’ expectations of $15.42 million. The business’s revenue was up 66.3% on a year-over-year basis.

Several analysts recently commented on the stock. Berenberg Bank assumed coverage on shares of Inspire Medical Systems in a research note on Wednesday, November 28th. They set a “sell” rating and a $31.00 target price for the company. Dougherty & Co assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, February 5th. They set a “buy” rating and a $64.00 target price for the company. Finally, Zacks Investment Research lowered shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, March 5th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $44.11.

Large investors have recently modified their holdings of the stock. Capital Financial Planning LLC purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $27,000. Arcadia Investment Management Corp MI purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $40,000. Great West Life Assurance Co. Can purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $50,000. Legal & General Group Plc lifted its position in shares of Inspire Medical Systems by 57.7% in the 4th quarter. Legal & General Group Plc now owns 1,843 shares of the company’s stock valued at $78,000 after acquiring an additional 674 shares in the last quarter. Finally, Cutler Group LP purchased a new stake in shares of Inspire Medical Systems in the 4th quarter valued at approximately $92,000.

TRADEMARK VIOLATION WARNING: This article was first posted by Highlight Press and is owned by of Highlight Press. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://highlightpress.com/2019/03/21/inspire-medical-systems-insp-ceo-timothy-p-herbert-sells-15000-shares.html.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Featured Article: Dividend Aristocrat Index

Insider Buying and Selling by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.